Syb's Immunology Year 2

Page 1

Sybghat Rahim

Year 2 Immunology Hypersensitivity and Allergy by Professor Sebastian Johnston

About 50% of us have allergic sensitisation (atopy), and 30% of us have allergic disease symptoms (allergy). We all make ‘appropriate’ immune responses to things that may harm us, such as viruses, bacteria, fungi and parasites. These immune responses are necessary to eliminate the pathogens and prevent or limit disease. There may be concomitant tissue damage as a side effect, but as long as the pathogen is eliminated quickly there is minimal damage and it is repaired easily. The immune responses involve antigen recognition by antibodies and cells of the immune system. Hypersensitivity reactions occur when immune responses are mounted against harmless foreign antigens (allergy, contact hypersensitivity), or autoantigens (autoimmune disease), alloantigens (serum sickness, transfusion reactions, graft rejection), and infectious agents (e.g. TB or Leprosy that are not cleared and lead to chronic immune mediated damage). A common feature in all of these hypersensitivity reactions is inflammation. This is a consequence of the action of immune molecules (antibodies, complement, cytokines, etc) and immune cells on sites of injury and/or infection. There is local vasodilation and increased blood flow to allow increased access of cells to the affected area, and there is also increased vascular permeability. This presents as redness and heat. Inflammatory mediators, cytokines and cells cause swelling and tissue damage may cause pain. Increased vascular permeability is caused by C3a, C5a, histamine and leukotrienes. Cytokines such as IL-1, IL-6, IL-8, IL-2 and TNF are chemokines. The inflammatory cells are trafficked by chemotaxis. Neutrophils, macrophages, lymphocytes and mast cells are activated. Hypersensitivity Classification by Gell & Coombs Type I: Immediate Hypersensitivity, IgE mediated. Type II: Antibody-dependent Cytotoxicity Type III: Immune Complex-Mediated Type IV: Delayed Cell Mediated, T cell mediated. Type I is immediate hypersensitivity .This includes anaphylaxis, asthma, rhinitis (seasonal or perennial) and food allergies. On a primary antigen exposure, IgE antibodies are produced and they bind to mast cells and basophils. You are now sensitised to the antigen. On the secondary antigen exposure there are even more IgE antibodies produced and the antigens cross-bridge IgE molecules on the mast cells and basophils to cause degranulation. This releases all the inflammatory mediators and there can be a systemic reaction. Type II is antibody dependent hypersensitivity. Clinical presentation of this type of hypersensitivity depends on the target tissue involved. Organ-specific autoimmune diseases are type II reactions, these include myasthenia gravis (ACh receptor antibodies in skeletal muscle = muscular weakness and tiring), glomerulonephritis (anti-glomerular basement membrane antibodies = renal failure), and pemphigus vulgaris (antibodies to epithelial cell cement = blistering skin eruption). There are also autoimmune cytopenias (blood cell destruction), including haemolytic anaemia, thrombocytopenia, and neutropenia. Haemolytic disease of the newborn (rhesus positive child born to rhesus negative mother = antibodies) is another example of a type II reaction. Type II reactions can be caused by drug allergies, hyper-acute graft rejection, transfusion reactions, pernicious anaemia (intrinsic factor blocking antibodies), and by idiopathic urticaria (antibodies against IgE receptor). In a type II reaction there can be antibody interaction with the cell surface antigen. Complement activation causes cell lysis and mast cell activation, and inflammation attracts cytotoxic cells such as neutrophils, eosinophils, monocytes and killer cells. Tissue damage results in altered function.

1


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.